Vista Pharmaceuticals has informed that pursuant to Section 96 of the Companies Act, 2013, read with Regulation 30 and other relevant provisions of the SEBI (Listing Obligations & Disclosure Requirements), 2015, pursuant to the Circular issued by the Ministry of Corporate Affairs and SEBI the 32nd Annual General Meeting of the Company will be held on Saturday, 30th day of September, 2023 at 11.00 AM through Video Conferencing and Other Audio-Visual Means (VC & OAVM). Further informed that the Company is providing e-voting facility to the shareholders to vote on the resolutions proposed to be passed at the 32nd Annual General Meeting of the Company will be held on Saturday, 30th day of September, 2023 at 11.00 AM through Video Conferencing and Other Audio-Visual Means (VC & OAVM). The e-voting will commence on Wednesday 27th September, 2023 at 9:00 AM and ends on Friday, 29th September 2023 at 5.00 PM. The Company has fixed Friday, 22nd day of September, 2023 as the cut-off date to reckon eligibility to vote on the e-voting platform. A copy of the notice calling 32nd AGM along with the copy of printed Annual report for the financial year 2022-23 which is being sent to the shareholders is uploaded on the company’s website of the Company.
The above information is a part of company’s filings submitted to BSE.